Home Biosimilar Antibodies Others Others antibody Vilobelimab (Anti-Complement C5) For research use only.
Not for use in humans.

Vilobelimab (Anti-Complement C5)

Synonyms: CaCP-29, IFX-1

Vilobelimab (Anti-Complement C5) is a monoclonal antibody targeting C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. It may be used in studies related to sepsis, COVID-19, etc. MW :145.9 KD.

Vilobelimab (Anti-Complement C5)

Purity & Quality Control

Batch: A310101 Purity: 99% Protein concentration: 5.5mg/ml Endotoxin Level: ＜1EU/mg
99

Biological Activity

Description Vilobelimab (Anti-Complement C5) is a monoclonal antibody targeting C5a, a pro-inflammatory complement division product that plays a central role in mediating organ dysfunction. It may be used in studies related to sepsis, COVID-19, etc. MW :145.9 KD.

Product Details

CAS No. 2250440-41-4
Isotype Human IgG4SP
Source CHO
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Vilobelimab (Anti-Complement C5) | Vilobelimab (Anti-Complement C5) supplier | purchase Vilobelimab (Anti-Complement C5) | Vilobelimab (Anti-Complement C5) cost | Vilobelimab (Anti-Complement C5) manufacturer | order Vilobelimab (Anti-Complement C5) | Vilobelimab (Anti-Complement C5) distributor